VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AEHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AEHRAehr Test Systems
$94.77$3.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAEHRFinancials

Aehr Test Systems (AEHR) Financials

29Y historyFree accessUpdated daily

Revenue growth has turned sharply negative, with 2026Q3 results showing a 43.7% decline and operating margins compressing to -41.0% due to high fixed-cost overhead.

AEHR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMMay'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97
Sales/Revenue45.26M58.97M66.22M64.96M50.83M16.6M22.29M21.06M29.55M18.9M14.5M10.02M19.68M16.49M15.52M13.74M11.67M21.41M39.04M27.35M23.8M16.08M15.8M15.09M12.57M31.04M24.5M18.15M40.8M42M
Revenue Growth %-26.39%-10.95%1.93%27.8%206.2%-25.53%5.87%-28.76%56.39%30.32%44.75%-49.11%19.38%6.23%12.99%17.67%-45.47%-45.17%42.74%14.92%48.02%1.77%4.69%20.08%-59.51%26.66%35.04%-55.53%-2.85%-
Cost of Goods Sold31.35M35.03M33.67M32.22M27.16M10.57M13.92M13.45M17.17M12.12M9.36M6.18M9.46M9.71M9.31M8.22M5.57M19.82M19.07M13.44M13.16M11.82M10.09M9.35M6.49M17.92M17.27M12.2M24.36M25.1M
COGS % of Revenue-59.41%50.85%49.59%53.44%63.66%62.45%63.9%58.09%64.12%64.52%61.69%48.07%58.9%60.01%59.87%47.72%92.6%48.85%49.13%55.31%73.49%63.87%61.98%51.62%57.74%70.46%67.24%59.7%59.76%
Gross Profit13.9M23.93M32.54M32.75M23.66M6.03M8.37M7.6M12.39M6.78M5.14M3.84M10.22M6.78M6.21M5.51M6.1M1.18M19.97M13.91M10.64M4.26M5.71M5.74M6.08M13.12M7.24M5.95M16.45M16.9M
Gross Margin %30.72%40.59%49.15%50.41%46.56%36.34%37.55%36.1%41.91%35.88%35.48%38.31%51.93%41.1%39.99%40.13%52.28%5.53%51.15%50.87%44.69%26.51%36.13%38.02%48.38%42.26%29.54%32.76%40.3%40.24%
Gross Profit Growth %--26.46%-0.62%38.37%292.32%-27.94%10.12%-38.62%82.68%31.78%34.05%-62.45%50.86%9.17%12.61%-9.68%415.46%-94.07%43.53%30.81%149.5%-25.32%-0.52%-5.63%-53.64%81.21%21.75%-63.85%-2.69%-
Operating Expenses29.4M28.25M22.46M19.37M15.87M10.21M10.92M11.88M11.47M11.71M11.3M10.53M9.72M10.08M10.71M10.53M10.85M26.39M14.16M12.86M10.18M9.24M10.22M10.46M10.58M11.64M12.43M10.58M12.25M13.2M
OpEx % of Revenue-47.9%33.93%29.82%31.21%61.53%48.97%56.41%38.81%61.96%77.92%105.13%49.41%61.15%69.03%76.66%92.96%123.25%36.26%47.03%42.78%57.45%64.66%69.32%84.21%37.51%50.73%58.29%30.01%31.43%
Selling, General & Admin17.51M17.78M13.75M12.24M10.05M6.56M7.53M7.72M7.29M7.05M6.97M6.47M6.32M6.87M6.53M5.96M6.09M20.62M7.66M6.54M5.84M5.21M5.57M5.92M6.55M7.26M7.93M6.89M8.62M8.9M
SG&A % of Revenue-30.16%20.76%18.84%19.77%39.53%33.78%36.68%24.67%37.32%48.1%64.58%32.12%41.68%42.05%43.42%52.2%96.34%19.61%23.9%24.55%32.43%35.27%39.22%52.09%23.4%32.36%37.98%21.12%21.19%
Research & Development11.67M10.46M8.72M7.13M5.82M3.65M3.39M4.15M4.18M4.66M4.32M4.06M3.4M3.21M4.19M4.57M4.76M5.76M6.5M6.32M4.34M4.02M4.64M4.54M4.04M4.38M4.5M3.69M3.63M3.7M
R&D % of Revenue-17.74%13.17%10.98%11.45%22%15.19%19.72%14.15%24.64%29.82%40.55%17.28%19.47%26.98%33.25%40.76%26.92%16.65%23.12%18.23%25.02%29.4%30.1%32.11%14.12%18.37%20.31%8.89%8.81%
Other Operating Expenses219K0000000000000000000000000000600K
Operating Income-15.5M-4.31M10.08M13.38M7.8M-4.18M-2.54M-4.28M915K-4.93M-6.15M-6.69M497K-3.31M-4.51M-5.02M-4.75M-24.8M5.81M1.05M455K-4.97M-4.51M-4.72M-4.5M1.47M-5.19M-4.63M4.2M3.7M
Operating Margin %-34.25%-7.31%15.22%20.59%15.35%-25.19%-11.42%-20.3%3.1%-26.08%-42.44%-66.82%2.52%-20.06%-29.04%-36.54%-40.68%-115.85%14.88%3.84%1.91%-30.94%-28.54%-31.3%-35.83%4.74%-21.19%-25.53%10.29%8.81%
Operating Income Growth %--142.8%-24.65%71.47%286.51%-64.32%40.47%-567.21%118.56%19.91%8.07%-1446.88%115.03%26.63%10.2%-5.69%80.85%-526.79%452.9%130.99%109.15%-10.33%4.55%-4.91%-405.91%128.35%-12.11%-210.31%13.49%-
EBITDA-11.83M-925K11.44M13.82M8.11M-3.87M-2.16M-3.84M1.33M-4.66M-5.95M-6.56M638K-2.98M-4.02M-4.45M-4.06M-24.16M6.29M1.37M795K-4.65M-4.13M-4.14M-3.84M2.12M-4.49M-4.18M4.68M4.3M
EBITDA Margin %-26.14%-1.57%17.28%21.28%15.95%-23.33%-9.69%-18.26%4.51%-24.65%-41.04%-65.47%3.24%-18.1%-25.87%-32.37%-34.77%-112.85%16.1%5.02%3.34%-28.93%-26.11%-27.45%-30.56%6.84%-18.32%-23.03%11.46%10.24%
EBITDA Growth %-521.26%-108.09%-17.24%70.53%309.38%-79.18%43.78%-388.59%128.6%21.73%9.27%-1128.06%121.37%25.67%9.67%-9.53%83.2%-484.36%357.42%72.83%117.09%-12.78%0.41%-7.84%-280.92%147.28%-7.44%-189.33%8.79%-
D&A (Non-Cash Add-back)3.67M3.39M1.36M450K307K310K384K431K417K271K203K135K141K322K491K573K690K644K474K323K340K323K384K582K662K651K703K453K479K600K
EBIT-15.28M-4.29M12.46M14.62M9.54M-2.16M-2.77M-4.96M854K-4.95M-6.17M-6.48M433K-3.34M-3.4M-3.42M-620K-25.06M5.97M2.5M789K-4.73M-4.51M-4.72M-4.5M1.47M-5.19M-4.63M4.2M3.68M
Net Interest Income835K1.4M2.39M1.25M13K-46K10K-252K-399K-678K-605K-130K-26K-49K-4K3K5K142K231K1.43M374K155K00000000
Interest Income835K1.4M2.39M1.25M13K010K000000003K5K142K231K1.43M374K155K00000000
Interest Expense0000046K0252K399K678K605K130K26K49K4K000000000000000
Other Income/Expense1.24M22K2.38M1.24M1.74M1.98M-221K-933K-460K-699K-621K81K-90K-82K1.1M1.6M4.13M-255K160K1.45M334K241K626K106K477K1.06M1.47M1.63M540K-1.14M
Pretax Income-14.27M-4.29M12.46M14.62M9.54M-2.2M-2.77M-5.21M455K-5.63M-6.78M-6.61M407K-3.39M-3.4M-3.42M-620K-25.06M5.97M2.5M789K-4.73M-3.88M-4.62M-4.03M2.53M-3.72M-3.01M4.74M2.6M
Pretax Margin %-31.53%-7.28%18.81%22.5%18.77%-13.28%-12.41%-24.73%1.54%-29.78%-46.72%-66.01%2.07%-20.55%-21.93%-24.91%-5.31%-117.05%15.29%9.15%3.31%-29.44%-24.58%-30.6%-32.03%8.16%-15.18%-16.57%11.61%6.19%
Income Tax-2.85M-381K-20.7M60K91K-177K36K27K-73K25K10K34K-15K30K-15K-49K-139K4.92M-4.6M75K-21K136K76K-74K1.24M1.05M-1.12M-677K2.33M-700K
Effective Tax Rate %19.98%8.88%-166.14%0.41%0.95%8.03%-1.3%-0.52%-16.04%-0.44%-0.15%-0.51%-3.69%-0.89%0.44%1.43%22.42%-19.62%-77.07%3%-2.66%-2.87%-1.96%1.6%-30.82%41.28%29.99%22.51%49.25%-26.92%
Net Income-11.42M-3.91M33.16M14.56M9.45M-2.03M-2.8M-5.24M528K-5.65M-6.79M-6.65M422K-3.42M-3.39M-3.37M-481K-29.97M10.57M2.43M810K-4.87M-3.96M-4.54M-5.27M-141K-2.6M-2.33M2.4M3.3M
Net Margin %-25.23%-6.63%50.07%22.41%18.59%-12.21%-12.57%-24.86%1.79%-29.91%-46.79%-66.35%2.14%-20.74%-21.83%-24.55%-4.12%-140.01%27.08%8.88%3.4%-30.29%-25.06%-30.11%-41.91%-0.45%-10.63%-12.84%5.89%7.86%
Net Income Growth %-149.95%-111.79%127.77%54.04%566.21%27.66%46.48%-1091.48%109.34%16.68%-2.08%-1675.12%112.34%-0.89%-0.47%-601.25%98.4%-383.47%335.46%199.75%116.63%-23.01%12.87%13.73%-3635.46%94.59%-11.8%-196.88%-27.12%-
Net Income (Continuing)-11.42M-3.91M33.16M14.56M9.45M-2.03M-2.8M-5.24M528K-5.65M-6.79M-6.65M422K-3.42M-3.39M-3.37M-481K-29.97M10.57M2.43M810K-4.87M-3.96M-4.54M-5.27M1.49M-2.6M-2.33M2.4M3.31M
Discontinued Operations000000000000000000000000000000
Minority Interest000000-21K-19K-20K-19K-20K-18K-21K-20K0000000000000000
EPS (Diluted)-0.37-0.131.120.500.34-0.09-0.12-0.230.02-0.35-0.52-0.550.04-0.36-0.38-0.38-0.06-3.551.240.300.11-0.66-0.55-0.63-0.74-0.02-0.38-0.340.360.74
EPS Growth %-148.56%-111.61%124%47.06%493.52%28%48.67%-1269%105.71%32.69%5.45%-1475%111.11%5.26%0%-533.33%98.31%-386.29%313.33%172.73%116.67%-20%12.7%14.86%-3675.51%94.84%-11.76%-194.44%-51.35%-
EPS (Basic)--0.131.150.520.36-0.09-0.12-0.230.02-0.35-0.52-0.550.04-0.36-0.38-0.38-0.06-3.551.320.310.11-0.66-0.55-0.63-0.74-0.02-0.38-0.340.380.77
Diluted Shares Outstanding30.7M29.58M29.62M29.21M27.77M23.46M22.88M22.39M22.78M16.27M13.09M12.05M11.89M9.55M9.02M8.78M8.56M8.44M8.51M8.22M7.61M7.42M7.25M7.16M7.15M7.18M6.81M6.85M6.76M4.5M
Basic Shares Outstanding30.7M29.58M28.82M27.79M26.01M23.46M22.88M22.39M21.73M16.27M13.09M12.05M10.88M9.55M9.02M8.78M8.56M8.44M8.01M7.75M7.51M7.42M7.25M7.16M7.15M7.07M6.81M6.85M6.33M4.3M
Dividend Payout Ratio------------------------------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowDeteriorating
Top Statement Risk

Customer concentration and EV cyclicality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Contraction Amid Market Headwinds

As reported in recent financial filings, AEHR experienced a significant revenue decline of 43.7% in 2026Q3 compared to the prior year, reflecting a broader deceleration in Silicon Carbide capacity expansion that has severely pressured the company's top-line growth trajectory across the most recent quarterly periods.

The sharp drop in revenue suggests that the company's reliance on a narrow set of EV-focused customers has left it vulnerable to current capital expenditure delays. This trend indicates that the previous growth phase, driven by rapid SiC adoption, has hit a cyclical plateau that may persist until new capacity cycles emerge.

Structural Margin Compression Under Pressure

Based on the latest income statement data, gross margins have compressed to 32.7% in 2026Q3, down from historical peaks exceeding 50%, which suggests that the current product mix is failing to provide the necessary pricing power to offset rising manufacturing costs during this period of lower volume.

The erosion of gross margins implies that the high-margin consumable revenue stream is not scaling sufficiently to compensate for the decline in system-level sales. Investors should monitor whether this margin degradation is a temporary byproduct of underutilized capacity or a permanent shift in the competitive landscape for wafer-level burn-in.

Operating Leverage Turning Into Liability

According to the company's income statement, operating margins have plummeted to -41.0% in 2026Q3, demonstrating that AEHR's high fixed-cost structure is currently amplifying losses as revenue falls below the critical break-even threshold required to sustain its existing research and administrative overhead levels.

The transition from positive operating income in 2024 to deep losses in recent quarters highlights the risks inherent in the company's operating model. Without a meaningful recovery in system shipments, the current expense base appears increasingly difficult to justify, potentially necessitating further cost-rationalization measures to preserve liquidity.

Earnings Quality Obscured by Compensation

Analysis of recent financial statements reveals that stock-based compensation, which reached $3.5M in 2026Q2, continues to weigh on the bottom line, masking the true extent of operational cash burn and complicating the assessment of core profitability during this period of significant net income volatility.

The presence of substantial non-cash expenses during a period of negative operating income warrants caution, as it suggests that reported EPS figures may not fully capture the economic reality of the business. Investors should focus on cash-based metrics to determine the sustainability of operations until the company returns to a consistent profit-generating state.

Sustainability of the Niche Moat

While the company maintains a proprietary position in wafer-level burn-in, the persistent -7.31% operating margin suggests that the market may be overestimating the durability of AEHR's competitive advantage in the face of potential in-house testing solutions by major semiconductor manufacturers.

The counter-argument to the bull case is that the current downturn may be more than just cyclical, potentially signaling a structural shift where customers seek more flexible, generic testing alternatives. If the 'razor-and-blade' model fails to generate sufficient recurring revenue, the company's valuation premium may face further downward pressure.

AEHR — Frequently Asked Questions

Quick answers to the most common questions about buying AEHR stock.

What was Aehr Test Systems's (AEHR) revenue in 2025?

For fiscal year 2025, Aehr Test Systems (AEHR) reported total revenue of $59.0M. This represents a 40.4% increase compared to $42.0M in 1997.

Is Aehr Test Systems (AEHR) profitable?

Aehr Test Systems (AEHR) reported a net loss of $3.9M for the fiscal year ending 2025.

What is Aehr Test Systems's operating profit margin?

Aehr Test Systems (AEHR) reported an operating income of $-4.3M, resulting in an operating profit margin of -7.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Aehr Test Systems's gross profit and gross margin?

Aehr Test Systems (AEHR) generated $23.9M in gross profit for the year, representing a gross profit margin of 40.6%. This demonstrates the company's core pricing power and production efficiency.